Niflumic acid

CAS No. 4394-00-7

Niflumic acid ( Actol; Donalgin; Nifluril; UP83 )

Catalog No. M14494 CAS No. 4394-00-7

Niflumic acid, a Ca2+-activated Cl- channel blocker, is an analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 40 In Stock
100MG 49 In Stock
200MG 68 In Stock
500MG 107 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Niflumic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Niflumic acid, a Ca2+-activated Cl- channel blocker, is an analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.
  • Description
    Niflumic acid, a Ca2+-activated Cl- channel blocker, is an analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.
  • Synonyms
    Actol; Donalgin; Nifluril; UP83
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX; Monocarboxylate transporter; Chloride channel protein ClC-Ka; PLA2; UGT
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    4394-00-7
  • Formula Weight
    282.22
  • Molecular Formula
    C13H9F3N2O2
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 56 mg/mL (198.42 mM)
  • SMILES
    O=C(C1=CC=CN=C1NC2=CC=CC(C(F)(F)F)=C2)O
  • Chemical Name
    2-[3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jabeen T, et al. Acta Crystallogr D Biol Crystallogr. 2005 Dec;61(Pt 12):1579-86.
molnova catalog
related products
  • Germacrone

    Germacrone, a major active component found in Curcuma zedoaria oil product, shows anti-inflammatory, antiandrogenic, and antivirus activities. It also inhibits the proliferation of glioma cells by promoting apoptosis.

  • Pamicogrel

    Pamicogrel is an inhibitor of COX. Pamicogrel has platelet anti-aggregatory properties which is under development by Kanebo for chronic arterial occlusion.

  • (R)-Naproxen

    An anti-inflammatory agent with analgesic and antipyretic properties.